Update on dentin desensitization.
Heymann
H O
HO
Department of Operative Dentistry, School of Dentistry, University of North Carolina, USA.
D001548:Benzalkonium Compounds / Q000627:therapeutic use; D002985:Clinical Protocols; D003806:Dentin Permeability; D003807:Dentin Sensitivity / Q000188:drug therapy* / Q000209:etiology; D017220:Dentin-Bonding Agents / Q000627:therapeutic use; D019234:Dentinal Fluid / Q000502:physiology; D005460:Fluorides, Topical / Q000627:therapeutic use; D005889:Gingival Recession / Q000150:complications; D005976:Glutaral / Q000627:therapeutic use; D006801:Humans; D006874:Hydrostatic Pressure; D008689:Methacrylates / Q000627:therapeutic use; D009566:Nitrates / Q000627:therapeutic use; D010070:Oxalates / Q000627:therapeutic use; D017680:Potassium Compounds / Q000627:therapeutic use; D012969:Sodium Fluoride / Q000627:therapeutic use; D014072:Tooth Abrasion / Q000150:complications
D001548:Benzalkonium Compounds; D017220:Dentin-Bonding Agents; D005460:Fluorides, Topical; C403445:Hurriseal; D008689:Methacrylates; D009566:Nitrates; D010070:Oxalates; D017680:Potassium Compounds; C111486:gluma desensitizer; D012969:Sodium Fluoride; C023844:potassium nitrate; D005976:Glutaral